Normally, TGF-Beta soothes the immune system, and some cancers use it to evade attack. It also triggers a signaling cascade ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 ...

Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

However, sell-offs present great opportunities to buy stocks with significant upside potential. Further, CRISPR Therapeutics ...

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of ...

Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...